Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

EVOLUS, INC. (EOLS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

EVOLUS, INC. (EOLS), most recent 12 months reported: revenue $316.49M, net loss $34.33M, free cash flow -$21.9M. Latest balance sheet on file: liquid cash $45.17M, total debt $156.74M, net cash -$111.57M. From SEC filings. Others in Pharmaceutical Preparations: IRONWOOD PHARMACEUTICALS, INC. · SINOVAC BIOTECH LTD · XERIS BIOPHARMA HOLDINGS, INC. · ARVINAS, INC. · Aurinia Pharmaceuticals Inc. · LIGAND PHARMACEUTICALS INCORPORATED · Protagonist Therapeutics, Inc · RIGEL PHARMACEUTICALS, INC.

Stock screener

Watchlist